Pharmafile Logo
Pharmafocus logo
Advanced Search
gavel

Roche sues Intas Pharma over patent dispute in India

April 18, 2016
Medical Communications, Sales and Marketing India, Roche, anaemia, chronic kidney, intas, intas pharmaceuticals, patent

Roche Pharmaceuticals is suing Indian-based Intas Pharmaceuticals, alleging that the company has infringed upon its patent rights to anaemia drug, …

News
drugs1

NICE recommends PTC Therapeutics’ Translarna to treat Duchenne muscular dystrophy

April 18, 2016
Sales and Marketing DMD, Duchenne Muscular Dystrophy, NICE, PTC Therapeutics, Translarna, regulation

Shares in drug maker PTC Therapeutics (Nasdaq: PTCT) jumped after the National Institute for Health and Care Excellence (NICE) backed …

News
shire_image

Shire announces new $400 million biologics plant and 400 new jobs in Ireland

April 18, 2016
Manufacturing and Production, Sales and Marketing IDA, Ireland, Shire, investment, meath, shire pharmaceuticals

Shire Pharmaceuticals has announced the expansion of its Irish operations with a new $400 million biologics plant set to deliver …

News
astrazeneca_building_white

AstraZeneca hold internal talks for Medivation takeover – reports

April 18, 2016
Manufacturing and Production, Sales and Marketing 7 billion, AstraZeneca, Medivation, Sanofi, jp morgan, merger, takeover

AstraZeneca (LSE: AZN) is said to have held initial internal talks concerning a potential £7 billion offer for US drug …

News
paris

Clinical trial initiated to help Paris attacks victims with PTSD

April 15, 2016
Medical Communications, Research and Development France, clinical trial, mcgill, mcgill university, terror attacks

Victims of the recent Paris terror attacks have been offered the opportunity to take part in a clinical trial, organised …

News
gilead-sciences

Gilead Sciences says Phase III trials for chronic HBV drug meet primary endpoints

April 15, 2016
Gilead Sciences, US FDA, chronic hepatitis B, drug trial

Biotech firm Gilead Sciences (NYSE: GILD) on Friday announced positive results from late-stage trials for its drug to treat chronic …

News
hospital

Repros Therapeutics says positive results from Phase II trial of uterine fibroids drug; shares jump

April 15, 2016
Medical Communications, Research and Development Repros Therapeutics, Shares, US FDA, drug trial, uterine fibroids

Shares in Repros Therapeutics (Nasdaq: RPRX) surged to close over 18% Thursday after the company announced positive mid-stage trial results …

News
pfizerbrussels

Pfizer fined for epilepsy drug price increase by UK antitrust regulator

April 15, 2016
Medical Communications CMA, Flynn Pharma, Pfizer, antitrust, competition and markets authority, epilepsy, fine, flynn

Pfizer has been fined for unfairly increasing the price of epilepsy drug Epanutin (phenytoin sodium) by the UK Competition and …

News
shutterstock_211705468

US annual spending on drugs rose 12.2% in 2015 – IMS

April 15, 2016
Medical Communications, Research and Development, Sales and Marketing IMS Health, drug spending

The total US spending on prescription drugs rose 12.2% to almost $425 billion in 2015 on the back of new …

News
cancer_cells

Roche’s cholesterol-lowering drug candidate shows promise in fighting prostate cancer

April 15, 2016
Medical Communications, Research and Development RO 48-9071, Roche, cholesterol, drug, missouri, oncology, university

Researchers from the University of Missouri have found that a compound developed by Roche Pharmaceuticals for the treatment of high …

News
clinical_trial_4

Synta Pharmaceuticals announces merger with Madrigal

April 15, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Phase II, Synta, madrigal, merger

Synta Pharmaceuticals (NASDAQ: SNTA) has announced a definitive merger agreement with Madrigal Pharmaceuticals under which the newly-formed company will focus …

News
mr058666-web

Merck appoints Maya Martinez-Davis as global head of oncology

April 14, 2016
Medical Communications Merck, maya martinez-davis, oncology

Merck has announced the appointment of Maya Martinez-Davis as the new global head of oncology at the German-based company. In …

Appointment

Merck says US FDA to review its Keytruda for head & neck cancer

April 14, 2016
Research and Development, Sales and Marketing Cancer Immunotherapy, Merck & Co, US FDA, keytruda

The US Food and Drug Administration has accepted Merck & Co’s (NYSE: MRK) supplemental biologics license application (sBLA) for its immunotherapy cancer …

News
aedes_aegypti_mosquito

Zika causes microcephaly and other birth defects, says CDC

April 14, 2016
Medical Communications, Research and Development CDC, Zika, Zika virus, birth defects, microcephaly

The US Centers for Disease Control and Prevention has concluded that the Zika virus is a cause of microcephaly and …

News
merck-sharp--dohme-corp

Merck says its Zepatier showed better efficacy and safety compared with competition in Phase III trials

April 14, 2016
Research and Development, Sales and Marketing Gilead, HCV, Merck & Co, Zepatier

US pharma giant Merck (NYSE: MRK) on Thursday said late-stage trials for its Zepatier (elbasvir and grazoprevir) to treat chronic …

News
abbvie_0

AbbVie announces positive Phase III results in hepatitis C drug

April 14, 2016
Manufacturing and Production, Research and Development AbbVie, hepatitis, phase III

AbbVie (NYSE: ABBV) has announced positive results from their Phase III evaluating the combination of Viekirax and Exviera, with or …

News

NICE issues new guidance on the safer use of controlled drugs

April 13, 2016
Medical Communications NICE, controlled drugs, guidance

The National Institute for Health and Care Excellence (NICE) has issued guidance bringing together legislation and existing advice on the …

News
sanofi_hq__boetie_hall

Sanofi reinforces collaboration with Stevenage Bioscience Catalyst with partnering office

April 13, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, Stevenage Bioscience Catalyst, academia, industry, partnership, pharma, stevenage

Sanofi has reinforced its collaboration with Stevenage Bioscience Catalyst with the opening of a new partnering office. This office will …

News
opdivo_1

Bristol-Myers Squibb cancer immunotherapy Opdivo approved in EU

April 13, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Bristol-Myers Squibb, Cancer, EU, NICE, approval, immunotherapy, opdivo

Bristol-Myers Squibb has announced that its potentially life-extending cancer immunotherapy, Opdivo (nivolumab), has been approved by the European Commission to …

News
fda_logo-web

US FDA committee recommends against fast-track approval of Clovis’ cancer drug, asks for more data

April 13, 2016
Medical Communications, Research and Development

Shares in Clovis Oncology Inc (Nasdaq: CLVS) closed down 5.4% Tuesday after the US Food and Drug Administration advisory committee recommended …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026